普萘洛尔联合局部硬化治疗≤5个月儿童大型血管瘤的临床疗效及并发症研究

Clinical efficacy and complication study of propranolol combined with local sclerotherapy in treatment of large hemangioma in children ≤5 months old

目的:研究口服普萘洛尔联合局部硬化治疗儿童大型血管瘤的临床疗效以及并发症发生情况。方法:选取2013年1月—2016年4月我院收治的年龄≤5个月的大型血管瘤患儿237例,分为两组。单纯治疗组86例采用单纯局部硬化治疗:在DSA或B超引导下,对瘤体采用多点穿刺,回抽见血后,将硬化剂缓慢注入瘤体组织中,至瘤体肿胀或变苍白为度。联合治疗组151例,口服普萘洛尔联合局部硬化治疗:24 h长程心电图正常后第2天始给予普萘洛尔口服,同时行局部硬化治疗,随访3个月~1.5年后,比较两组临床疗效及并发症的发生情况。结果:联合治疗组的总有效率96.7%(146/151)高于单纯治疗组89.5%(77/86),差异有统计学意义(χ~2=5.045,P<0.05)。且联合治疗组的治愈率71.5%(108/151)也高于单纯治疗组47.7%(41/86),差异有统计学意义(χ~2=13.350,P<0.01)。联合治疗组的并发症发生率25.8%(39/151)低于单纯治疗组38.4%(33/86),差异有统计学意义(χ~2=4.077,P<0.05)。结论:口服普萘洛尔联合局部硬化治疗在有效率上明显优于单纯局部硬化治疗,且并发症少。

Objective： To study the clinical efficacy and occurrence of complication of oralpropranolol combined with local sclerotherapy for the treatment of large hemangioma in children. Methods ： Totally 237 infants（≤ 5 months old） with large hemangioma in Wuhan Children’s Hospital from January 2013 to April 2016 were selected and divided into two groups. The patients in simple treatment group（86 cases） were given local sclerosis treatment. Procedures were as follows ： under the guidance of DSA or B ultrasound, multi-point puncture was performed on the tumor, after withdrawing blood, the sclerotherapy agent was slowly injected into the tumor tissue. The patients in combined treatment group （151 cases） were orally given propranolol combined with local sclerotherapy after 24 h long-term ECG is normal. 237 cases were followed up for 3 months to 1.5 years, and the clinical efficacy and complications in two groups were compared. Results ： The total effective rate in combined treatment group was 96.7% （146/151） , which was higher than that of simple treatment group （89.5% , 77/86） , with significant difference （X2 = 5.045 , P〈0.05 ）. The cure rate of combined treatment group was 71.5% （108/151） , which was higher than that of simple treatment group （47.7% , 41/86）, with significant difference （x2=13.350, P〈0.01）. The incidence of complications in combined treatment group was 25 . 8 % , which was lower than that of the simple treatment group （38.4% ）, with significant difference （x2=4.077 , P〈0.05 ）. Conclusion： Oral propranolol combined withlocal sclerotherapy is significantly better than the local sclerotherapy, with less comparison.